Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Oing

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Cancer Letters|March 13, 2018
BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapyChristoph Oing, Pierre Tennstedt, Ronald Simon, et al.
Nature Reviews. Urology|March 9, 2021
Late adverse effects and quality of life in survivors of testicular germ cell tumourMichal Chovanec, Jakob Lauritsen, Mikkel Bandak, et al.
Journal of Cancer Research and Clinical Oncology|September 21, 2018
Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study GroupMartin Fenner, Christoph Oing, Annette Dieing, et al.
Therapeutic Advances in Medical Oncology|June 4, 2026
Treatment options in platinum-refractory male germ cell cancers: current standards and future directionsMarco Oltrecolli, Domiziana Alaimo, Fabrizio Di Costanzo, et al.
Histopathology|September 10, 2021
Primary mediastinal germ cell tumours: an immunohistochemical and molecular diagnostic approachAlexander Fichtner, Annika Richter, Simon Filmar, et al.
Annals of Surgical Oncology|July 17, 2021
Radical Hemiscrotectomy and En Bloc Orchidectomy: Surgical Technique and Perioperative and Oncologic Outcomes of a Supra-Regional UK Referral CentreChristian Daniel Fankhauser, Allaudin Issa, Esther W C Lee, et al.
Molecular Cancer Therapeutics|March 9, 2026
Exploring DNA Damage Repair Therapeutics in Prostate Cancer beyond BRCAnessFabrizio Di Costanzo, Jack Williamson, Craig N Robson, et al.
Frontiers in Oncology|April 11, 2024
Hyperthyroidism in non-seminomatous testicular germ cell tumors: two case reports and literature reviewDiletta Favero, Christoph Oing, Christoph Seidel, et al.
Cancer Letters|July 28, 2021
The developmental origin of cancers defines basic principles of cisplatin resistanceMargaretha A Skowron, Christoph Oing, Felix Bremmer, et al.
Journal of Cancer Research and Clinical Oncology|December 16, 2019
Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case seriesChristoph Oing, Marcus Hentrich, Anja Lorch, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Cancer Letters|March 13, 2018
BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapyChristoph Oing, Pierre Tennstedt, Ronald Simon, et al.
Nature Reviews. Urology|March 9, 2021
Late adverse effects and quality of life in survivors of testicular germ cell tumourMichal Chovanec, Jakob Lauritsen, Mikkel Bandak, et al.
Journal of Cancer Research and Clinical Oncology|September 21, 2018
Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study GroupMartin Fenner, Christoph Oing, Annette Dieing, et al.
Therapeutic Advances in Medical Oncology|June 4, 2026
Treatment options in platinum-refractory male germ cell cancers: current standards and future directionsMarco Oltrecolli, Domiziana Alaimo, Fabrizio Di Costanzo, et al.
Histopathology|September 10, 2021
Primary mediastinal germ cell tumours: an immunohistochemical and molecular diagnostic approachAlexander Fichtner, Annika Richter, Simon Filmar, et al.
Annals of Surgical Oncology|July 17, 2021
Radical Hemiscrotectomy and En Bloc Orchidectomy: Surgical Technique and Perioperative and Oncologic Outcomes of a Supra-Regional UK Referral CentreChristian Daniel Fankhauser, Allaudin Issa, Esther W C Lee, et al.
Molecular Cancer Therapeutics|March 9, 2026
Exploring DNA Damage Repair Therapeutics in Prostate Cancer beyond BRCAnessFabrizio Di Costanzo, Jack Williamson, Craig N Robson, et al.
Frontiers in Oncology|April 11, 2024
Hyperthyroidism in non-seminomatous testicular germ cell tumors: two case reports and literature reviewDiletta Favero, Christoph Oing, Christoph Seidel, et al.
Cancer Letters|July 28, 2021
The developmental origin of cancers defines basic principles of cisplatin resistanceMargaretha A Skowron, Christoph Oing, Felix Bremmer, et al.
Journal of Cancer Research and Clinical Oncology|December 16, 2019
Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case seriesChristoph Oing, Marcus Hentrich, Anja Lorch, et al.
Pageof 8